8-119793396-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_003184.4(TAF2):​c.1247C>A​(p.Pro416His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

TAF2
NM_003184.4 missense

Scores

7
7
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 9.44

Publications

2 publications found
Variant links:
Genes affected
TAF2 (HGNC:11536): (TATA-box binding protein associated factor 2) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that is stably associated with the TFIID complex. It contributes to interactions at and downstream of the transcription initiation site, interactions that help determine transcription complex response to activators. [provided by RefSeq, Jul 2008]
TAF2 Gene-Disease associations (from GenCC):
  • microcephaly-thin corpus callosum-intellectual disability syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.901

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TAF2NM_003184.4 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 26 ENST00000378164.7 NP_003175.2 Q6P1X5B3KMD8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TAF2ENST00000378164.7 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 26 1 NM_003184.4 ENSP00000367406.2 Q6P1X5
TAF2ENST00000686879.1 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 27 ENSP00000509206.1 A0A8I5KV60
TAF2ENST00000685235.1 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 26 ENSP00000510174.1 A0A8I5QJR0
TAF2ENST00000688645.1 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 25 ENSP00000509978.1 A0A8I5KSY6
TAF2ENST00000523904.2 linkc.1133C>A p.Pro378His missense_variant Exon 9 of 25 3 ENSP00000430832.2 H0YC37
TAF2ENST00000690144.1 linkc.1247C>A p.Pro416His missense_variant Exon 10 of 26 ENSP00000510548.1 A0A8I5KUQ2
TAF2ENST00000685202.1 linkn.1247C>A non_coding_transcript_exon_variant Exon 10 of 27 ENSP00000509214.1 A0A8I5QJD7
TAF2ENST00000685663.1 linkn.*1119C>A non_coding_transcript_exon_variant Exon 12 of 28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*2714C>A non_coding_transcript_exon_variant Exon 9 of 25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*948C>A non_coding_transcript_exon_variant Exon 8 of 24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*965C>A non_coding_transcript_exon_variant Exon 11 of 27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*1062C>A non_coding_transcript_exon_variant Exon 9 of 25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000688037.1 linkn.*666C>A non_coding_transcript_exon_variant Exon 7 of 23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*965C>A non_coding_transcript_exon_variant Exon 11 of 26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*483C>A non_coding_transcript_exon_variant Exon 10 of 26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000690922.1 linkn.1247C>A non_coding_transcript_exon_variant Exon 10 of 26 ENSP00000509498.1 A0A8I5KPW0
TAF2ENST00000691880.1 linkn.*903C>A non_coding_transcript_exon_variant Exon 9 of 25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*948C>A non_coding_transcript_exon_variant Exon 8 of 25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*1115C>A non_coding_transcript_exon_variant Exon 12 of 28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*634C>A non_coding_transcript_exon_variant Exon 9 of 25 ENSP00000509603.1 A0A8I5QJI9
TAF2ENST00000685663.1 linkn.*1119C>A 3_prime_UTR_variant Exon 12 of 28 ENSP00000508988.1 A0A8I5KUD2
TAF2ENST00000685684.1 linkn.*2714C>A 3_prime_UTR_variant Exon 9 of 25 ENSP00000509441.1 A0A8I5KY57
TAF2ENST00000685824.1 linkn.*948C>A 3_prime_UTR_variant Exon 8 of 24 ENSP00000510262.1 A0A8I5KU60
TAF2ENST00000685876.1 linkn.*965C>A 3_prime_UTR_variant Exon 11 of 27 ENSP00000510493.1 A0A8I5KUD2
TAF2ENST00000685993.1 linkn.*1062C>A 3_prime_UTR_variant Exon 9 of 25 ENSP00000510102.1 A0A8I5KU60
TAF2ENST00000688037.1 linkn.*666C>A 3_prime_UTR_variant Exon 7 of 23 ENSP00000510169.1 A0A8I5KRI4
TAF2ENST00000689919.1 linkn.*965C>A 3_prime_UTR_variant Exon 11 of 26 ENSP00000510768.1 A0A8I5KUD2
TAF2ENST00000690808.1 linkn.*483C>A 3_prime_UTR_variant Exon 10 of 26 ENSP00000509791.1 A0A8I5KVC1
TAF2ENST00000691880.1 linkn.*903C>A 3_prime_UTR_variant Exon 9 of 25 ENSP00000508515.1 A0A8I5KNG3
TAF2ENST00000692518.1 linkn.*948C>A 3_prime_UTR_variant Exon 8 of 25 ENSP00000508959.1 A0A8I5KU60
TAF2ENST00000692707.1 linkn.*1115C>A 3_prime_UTR_variant Exon 12 of 28 ENSP00000509024.1 A0A8I5KUD2
TAF2ENST00000692916.1 linkn.*634C>A 3_prime_UTR_variant Exon 9 of 25 ENSP00000509603.1 A0A8I5QJI9
TAF2ENST00000685503.1 linkn.*670-1937C>A intron_variant Intron 10 of 25 ENSP00000509198.1 A0A8I5KXS3
TAF2ENST00000686098.1 linkn.1192-1937C>A intron_variant Intron 9 of 24 ENSP00000509102.1 A0A8I5KXP3
TAF2ENST00000689164.1 linkn.1078-1937C>A intron_variant Intron 8 of 23 ENSP00000508729.1 A0A8I5KR26
TAF2ENST00000691847.1 linkn.*579-1937C>A intron_variant Intron 9 of 23 ENSP00000509663.1 A0A8I5QJJ6

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460680
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
726722
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33446
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26088
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86218
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111260
Other (OTH)
AF:
0.00
AC:
0
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Mar 01, 2019
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly-thin corpus callosum-intellectual disability syndrome Uncertain:1
Dec 01, 2013
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
-0.070
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T
Eigen
Uncertain
0.60
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.070
D
MetaRNN
Pathogenic
0.90
D
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.4
L
PhyloP100
9.4
PrimateAI
Pathogenic
0.82
D
PROVEAN
Pathogenic
-6.8
D
REVEL
Uncertain
0.41
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.74
P
Vest4
0.90
MutPred
0.76
Loss of loop (P = 0.0112);
MVP
0.38
MPC
0.79
ClinPred
0.99
D
GERP RS
5.7
Varity_R
0.78
gMVP
0.90
Mutation Taster
=7/93
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398124655; hg19: chr8-120805636; API